Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Levetiracetam NDC 65162-685 by Amneal Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

690afec4-figure-01 - levetiracetam oral solution 1

690afec4-figure-01 - levetiracetam oral solution 1

690afec4-figure-02 - levetiracetam oral solution 2

690afec4-figure-02 - levetiracetam oral solution 2

This text seems to be presenting some data related to a medical study involving two groups of patients. The first group, with 95 participants, was likely given a placebo treatment (which means they were given a substance that has no therapeutic effect). The second group had two sub-groups with 97 and 101 participants, respectively, and they were given different doses of a medication called Levetiracetam. The first sub-group (with 97 participants) probably took 1000 mg/day of the medication, while the second sub-group (with 101 participants) took 3000 mg/day. However, without further context or information, it is not clear what the study was evaluating or what the results were.*

690afec4-figure-03 - levetiracetam oral solution 3

690afec4-figure-03 - levetiracetam oral solution 3

690afec4-figure-04 - levetiracetam oral solution 4

690afec4-figure-04 - levetiracetam oral solution 4

This text provides information related to the percentage of effectiveness of a certain medication, as well as the dosage used for treatment. The medication in question is likely Levetiracetam, administered at a dosage of 3000 mg per day. The percentages provided may relate to success rates or side effects, but without further context, it is difficult to determine their exact meaning. The asterisk (*) may indicate a footnote or additional information.*

690afec4-figure-05 - levetiracetam oral solution 5

690afec4-figure-05 - levetiracetam oral solution 5

This appears to be data presented in the form of percentages for two groups of patients who received either a placebo or a drug called Levetiracetam. However, without context or additional information such as what condition the patients were suffering from, it is not possible to provide a detailed description of the data.*

figure 5 - levetiracetam oral solution 6

figure 5 - levetiracetam oral solution 6

This appears to be a data table with two percentage values, "45%" and "43.1%". The two values possibly pertain to the effectiveness or side effects of a medication or treatment. The table also includes two groups labeled "Placebo (N=51)" and "Levetiracetam (N=58)," indicating the number of subjects in each group. However, without further context or information, it is difficult to determine the exact meaning or purpose of the table.*

690afec4-figure-07 - levetiracetam oral solution 7

690afec4-figure-07 - levetiracetam oral solution 7

100 mL/4 Oz - levetiracetam oral solution 8

100 mL/4 Oz - levetiracetam oral solution 8

This is information related to the usual dosage, storage, and distribution of a medication called Levetiracetam in the form of oral solution. The pharmacist should dispense it in a tightly closed container to protect it from light and to make it child-resistant. The medication should be stored at a temperature of 20 to 25°C and out of reach of children. Amneal Pharmaceuticals LLC in Bridgewater, NJ 08807 is the distributor of this medication. Additionally, the packaging includes a net contents of 118 mL and a required medication guide for patients.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.